VeriMomtetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
Pregnancy-safe products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Related ingredients
Frequently asked questions
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate est-il sûr pendant l'allaitement ?
- No data located showing lactational transfer, mammary toxicity, or reproductive system effects. No SCCS/CIR opinion or harmonised hazard for this ingredient. Therefore default hazard/mechanism = 0 and exposure from topical cosmetic use is considered negligible based on peptide structure and marketed aqueous/glycerin formulations. Sources: DSM Syn‑HYCAN product literature, EPA CompTox, PubMed search (no relevant studies found).
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate est-il sûr pour la peau de bébé ?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- Comment VeriMom évalue-t-il tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate ?
- VeriMom évalue tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.